BMY - Bristol-Myers Squibb Company
Bristol-Myers Squibb Company Logo

BMY - Bristol-Myers Squibb Company

https://www.bms.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.

52W High
$61.84
52W Low
$42.96
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.36
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
18.93
Forward P/E (<15 better)
7.82
EV/EBITDA (<8 favorable)
8.84
EV/Revenue (<3 favorable)
2.79
P/S (TTM) (<3 favorable)
2.01
P/B (<3 favorable)
5.50
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.07%
Institutions (25–75% balanced)
82.85%
Shares Outstanding
2,035,440,000
Float
2,031,833,000
Dividend Yield (2–6% sweet spot)
0.05%
Ex‑Dividend Date
2025-07-03
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
47,703,998,000
Gross Profit (TTM)
35,262,001,000
EPS (TTM)
2.49
Profit Margin (>10% good)
0.11%
Operating Margin (TTM) (higher better)
0.34%
ROE (TTM) (>15% strong)
0.29%
EPS YoY (Quarterly) (>10% good)
-0.23
Revenue YoY (Quarterly) (>8% good)
0.01
Momentum
Bearish momentum
Value
0.0398
Previous
-0.0004
Trend
Rising
Signal Cross
Crossed Up Today
As of
Sep. 11, 2025